JNJ compared with PFE: revenue, margins and what each company keeps, and the suppliers and customers both name

JNJJohnson & Johnson

Mkt capRevenueRevenue

PFEPfizer Inc

Mkt capRevenueRevenue

Compare

JNJJohnson & Johnson

PFEPfizer Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only JNJ 23

MRKMercksupplier

PTGXProtagonist Therapeuticssupplier

GPKGraphic Packagingsupplier

ZYMEZymeworkssupplier

19 more · JNJ chain ›

Shared 0

No shared counterparties.

Only PFE 34

MIRMMirum Pharmaceuticalscustomer

ICUIICU Medicalcustomer

BEAMBeam Therapeuticssupplier

ADPTAdaptive Biotechnologiessupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

30 more · PFE chain ›

JNJJohnson & Johnson

271.04· pre 270.94· delayed

Mkt cap$657.7BRevenue$25.4BQ3 FY26Revenue$94.2BFY25

PFEPfizer Inc

30.71· pre 31.03· delayed

Pre-marketNov 2 '26delayed

Mkt cap$174.0BRevenue$15.0BQ2 FY26Revenue$62.6BFY25

Compare

Pre-marketNov 2 '26delayed

JNJJohnson & Johnson

PFEPfizer Inc

271.04pre 270.94delayed

Price

30.71pre 31.03delayed

$657.7B

Mkt cap

$174.0B

Q3 FY26$25.4B

Revenue

$15.0BQ2 FY26

FY25$94.2B

Revenue

$62.6BFY25

JNJ271.04vsPFE30.71Pre-marketNov 2 '26delayed